Lates News

Every AI Express, China Post Securities released a research report on April 17th giving Wumei Biotechnology (603983.SH) a "hold" rating. The main reasons for the rating include: 1) Income split: single product and double brand driving, significant differentiation in channel structure; 2) Profit split: increased advertising + depreciation of large buildings, squeezing short-term profit space; 3) Company outlook: channel optimization + dual brand operation, jointly driving the company's future development. (Daily Economic News)